Amphotericin B is a broad-spectrum polyene antifungal that binds ergosterol to form membrane-disrupting pores in fungal cells, remaining a cornerstone treatment for serious invasive fungal infections despite its narrow therapeutic index. Simson Pharma's Amphotericin B reference standard and impurities support the rigorous potency and degradation-product testing this critical-care antifungal demands.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Amphotericin B Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.